LycoRed enters infant formula market
This article was originally published in The Tan Sheet
LycoRed announces Nov. 20 the launch of a line of "advanced oily blends featuring proprietary fatty acid premixes" designed for use in infant formula. The oily blend contains a "custom made composition of long chain polyunsaturated fatty acids and other oily soluble ingredients," the firm says. Product manufacturing will be at LycoRed's "new specialized lipid formulation facility" in the UK, the firm says. LycoRed Managing Director Peter Gallagher says, "Our goal is to penetrate this market with hot, new lipids that will allow manufacturers to create healthy and cutting-edge products. Investment in our premix facilities is the cornerstone of our strategy." LycoRed is the "leading European manufacturer for innovative premixes" and entered the U.S. premix market in July, according to a release...
You may also be interested in...
A trio of newly finalized guidance documents from the US agency dated 25 September explain how the Accreditation Scheme for Conformity Assessment pilot will work, and what biocompatibility and safety standards will apply.
Approval of Alaway Preservative Free (ketotifen fumarate, 0.035) comes 15 months after FDA submitted a complete response letter to Bausch and the active ingredient developer, Eton Pharmaceuticals.
Unfounded expectation some firms have for FDA to protect their investments in preparing successful NDI notifications is part of industry’s overall interest in increased regulation of the market, says Steven Tave, Office of Dietary Supplement Programs director.